A look at The Draft National Pharmaceuticals Policy, 2011
This post gives an insight into the Draft National Pharmaceuticals Policy released last month. The policy’s objective is: to put in place a regulatory framework for pricing of drugs so as to ensure availability of essential medicines at reasonable prices while providing opportunity for innovation and competition. The 2011 policy follows two failed attempts (2002 and 2006) to replace the 1994 policy currently still in place. Main Features of the Policy Prices would be regulated based on essentiality of drugs […]
A look at The Draft National Pharmaceuticals Policy, 2011 Read More »






